Top Markets
#1 EXOD EXOD +56.80%
#2 Arowana Arowana +10.12%
#3 Fake World Assets Fake World Assets +4.62%
#4 Dual Dual +3.58%
#5 Ontology Gas Ontology Gas +2.75%
#6 The Black Bull The Black Bull +2.59%
#7 Orochi Network Orochi Network +2.47%
#8 WYDE: End Hunger WYDE: End Hunger +2.19%
#9 SIXSEVEN SIXSEVEN +2.17%
#10 LAB LAB +1.95%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Clasificación en acciones #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Precio por acción
$0.08765138
Última sincronización: 2025-12-23
Capitalización bursátil
$1.11M
Cambio (1 día)
0.45%
Cambio (1 año)
-28.78%
País
CA
Comercio Psyence Group Inc. (PSYG)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Psyence Group Inc. (PSYG)
La acción Psyence Group Inc. (símbolo: PSYG) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 15, 2026.
Una acción PSYG comprada antes de Aug 15, 2026 equivaldría hoy a 0 acciones PSYG.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US